NEWS
Crossing Disciplines to Explore Questions about Cancer
“A lot of the easy stuff [in cancer research] has been done,” Dr. Elizabeth Blackburn said over the weekend at the annual meeting of the American Association for Cancer Research (AACR), currently under way in Orlando, FL. The “face of cancer research” is much more interdisciplinary today than in the past, and this is how new frontiers will be explored, she added.
Dr. Blackburn, who is president of AACR and a Nobel laureate for her pioneering research on telomeres, noted that life sciences, physical sciences, and engineering are converging: “Over and over, we are seeing what we thought were separate disciplines come together.” Read more > >
Latest Surveillance Data Show Cancer Cases and Deaths Continue to Decline
Lung cancer death rates in women decreased for the first timePatients Taking Imatinib for CML Have Similar Risk of Death as General Population
Patients in remission for at least 2 years are more likely to die from causes other than leukemiaRisk of Second Cancer Following Radiation Therapy Is Small
Study finds less than 10 percent of second solid cancers could be linked to radiation therapyImmunotherapy Targets Pancreatic Tumors from the Outside
Antibody spurs immune system to attack tissue surrounding tumorsBreast Cancer Genomes Sequenced to Study Drug Response
Study of 50 genomes underscores the heterogeneity of breast cancerCombination of Two Targeted Cancer Drugs Appears Safe in Early Testing
Researchers observed some preliminary signs of anticancer effects for several cancersTest May Detect Mesothelioma at the Earliest Stages
Assay identifies proteins that may detect mesothelioma in people exposed to asbestos
A MESSAGE TO READERS
NCI FY2012 Budget Proposal Available Online
NCI recently released The Nation's Investment in Cancer Research, a professional judgement budget for fiscal year 2012. The theme for this year’s document is “Cancer: Changing the Conversation.”
IN DEPTH
Menopausal Estrogen Therapy Benefits and Risks Vary by Age, WHI Analysis Suggests
Estrogen-only therapy decreased breast cancer risk in postmenopausal women with hysterectomy regardless of age
For People with Rare Skin Cancer Syndrome, Drug Brings Relief and Hope
A targeted drug called GDC-0449 yields “stunning” results in clinical trial
Genome Study of Multiple Myeloma Opens New Avenues for Research
Findings identify patients who may benefit from experimental drugs
Featured Clinical Trial: Inhibiting Tumor Angiogenesis in Metastatic Hormone-Refractory Prostate Cancer
Will new antibody be safe and effective in men with advanced disease?
UPDATES
FDA Update
- FDA Approves New Treatment for Late-Stage Melanoma
CMS Update
- CMS Issues Proposed Decision Memo on Medicare Coverage of Sipuleucel-T
Legislative Update
- Congressional Staffers and Advocates Take Part in Project Cancer Education
Notes
- NIH Research Plan Aims to Prevent and Treat Obesity
- Member Sites Selected for Cancer Immunotherapy Trials Network
- Free Telephone Workshop Series for Cancer Survivors
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
